drugset / Trial / NCT06242145

Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke

NCT06242145

Phase 3 Completed 580 enrolled Kafrelsheikh University
RandomizedParallel-groupDouble-blindTreatment

Summary

Along with the current clinical trial, the efficacy and safety of a 300 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel ischemic stroke compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.

Timeline

Start
2023-01-01
Primary completion
2024-07-01
Completion
2024-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cilostazol Small molecule 100 mg
Comparator Clopidogrel Small molecule 75 mg

Indications